During expansion, a PR occurred in 2 patients with BRAF-mutated melanoma (1 KRAS-WT and 1 of unknown KRAS status) and 1 with BRAF-WT, KRAS-WT melanoma; all three received E6201 320 mg/m2 once-weekly. The gene discussed is KRAS; the disease is melanoma.